Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Sai Life Sciences IPO GMP: Subscription BEGINS
Sai Life Sciences IPO GMP price today: Day 2 subscription today; check latest grey market premium
According to multiple websites that track grey market activities, Sai Life Sciences’s shares are commanding a premium of Rs 37. This translates into a GMP of 6.74 per cent
Sai Life Sciences IPO fully subscribed on second day of bidding; Retail portion booked only 30%
The Qualified Institutional Buyers (QIBs) booked their quota 2.88 times even as the investors in other categories adopted a cautious approach. The portion reserved for retail investors was booked 30% whereas the Non-Institutional Investors (NIIs) booked 28% of the shares set aside for them.
Sai Life Sciences IPO fully subscribed on Day 2; QIBs drive demand
The unlisted shares of Sai Life Sciences were trading at Rs 586 apiece, reflecting a grey market premium (GMP) of Rs 37 or 6.74 per cent per share over the upper end of the IPO price band of Rs 549
Sai Life Sciences IPO: Issue Date, Price Band, GMP, Minimum Investment, Lot Size, Read Here
Issue Size. Sai Life Sciences IPO is a book-built issue of Rs 3,042.62 crores. The issue is a combination of a fresh issue of 1.73 crore shares aggregating
Sai Life Sciences IPO Subscribed 89% On Day 2
Sai Life Sciences Ltd.'s initial public offering entered the second day on Thursday. It was subscribed 0.89 times or 89% as of 11:06 a.m. The company aims to raise Rs 3,042 crore via the offering.
Sai Life Sciences IPO Day 1 Live Updates: Issue subscribed 84% on first day; QIB portion fully booked; check latest GMP
At the end of the first day of the bidding process, Sai Life Sciences IPO was subscribed 84%, led by strong demand from institutional investors. The QIB portion was booked 2.62 times while the NII portion was subscribed 15%. The retail portion, meanwhile, garnered 18% bids.
Sai Life Sciences IPO: Worth your money? Check GMP, price band, and more
Sai Life Sciences IPO opens for public subscription today, Wednesday, December 11, 2024, and will close on Friday, December 13, 2024
Sai Life Sciences IPO subscribed 84% on the first day; Check price band, GMP, other details
Shares of Sai Life Sciences were trading at a premium of ₹28 in the grey market, at 4:30 PM on December 11, as per reports. The latest GMP for Sai Life Sciences IPO indicates an expected listing price of ₹577 per share with a potential listing gain of 5%.
Sai Life Sciences IPO subscribed 84%, QIB portion booked 2.62 times on Day 1; Check GMP, other details
Sai Life Sciences IPO opened for for public subscription on Wednesday, December 11 and will close on Friday, December 13. The public issue has received healthy booking from the QIB segment on Day 1.
Sai Life Sciences IPO Day 1: Issue subscribed 84% led by QIBs. Check GMP, other key details
Retail investors subscribed 8%, non-institutional investors 4%, while qualified institutional buyers made no bids yet for the Rs 3,042.62 crore IPO. The issue includes a fresh allotment of shares worth Rs 950 crore and an OFS of Rs 2,
TPG-backed Sai Life Sciences IPO opens today
TPG Capital-backed Sai Life Sciences IPO opens at ₹522-549, with ₹3,043-crore valuation, offering fresh shares and stake sale.
moneycontrol.com
44m
Sai Life Sciences IPO gets subscribed 90% on Day 2 so far; QIB portion booked 2.62x
The public issue of
Sai
Life
Sciences
kept its positive momentum on Day 2 of its subscription as well and saw 90% subscription so far on December 12 with qualified institutional buyers or QIBs ...
3h
on MSN
IPO subscription: Vishal Mega Mart, One Mobikwik Systems, Sai Life Sciences & Inventurus Knowledge Solutions
While IPOs of Vishal Mega Mart, One Mobikwik Systems and Sai Life Sciences opened on December 11, share sale for Inventurus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Commuting 1,500 sentences
FBI director resigning
Biden's nominee rejected
Meta donates $1M to Trump
Granola bars recalled
Director of Voice of America
AZ sues over water pumping
Taliban minister killed
Hit by cyberattack
Former US Rep. Leach dies
House approves defense bill
How to catch the Geminids
Alexander brothers arrested
Nasdaq diversity rules axed
Class action to proceed
Man arrested for assault?
UNC hires Bill Belichick
Testifies at House hearing
To stream live on Hulu
2024 top search trends
Macy’s accounting probe
Herpes infection study
Speaks out after acquittal
Sheriff defies new policy
Saudi Arabia wins 2034 bid
Russia to use new missile?
Trump picks ambassadors
Dengue spreads in Americas
Related topics
IPO
Serbia
Springfield Armory
Leidos
Biology
Feedback